Phase II Study of AZD0530 (NSC 735464) in Patients With Previously Treated Metastatic Colorectal Cancer.

Trial Profile

Phase II Study of AZD0530 (NSC 735464) in Patients With Previously Treated Metastatic Colorectal Cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Saracatinib (Primary)
  • Indications Colorectal cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 14 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 23 Mar 2011 Planned End Date changed from 1 Feb 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.
    • 09 Jun 2010 Planned end date changed from 1 Apr 2008 to 1 Feb 2011 as reported by Clinical trials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top